Coya Therapeutics, Inc.

COYA

Coya Therapeutics, Inc.

COYA

Insider Sentiment (TTM):

Last Purchase:2024-11-14Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:8,114,099Shares Outstanding:22,644,304Institutional Ownership Pct.:35.83%

Earnings Market Reaction:

Filing Date:2026-08-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	43	51	47	28	30	36	38	31	37	36	33	11
Prepaid Expense And Other Assets Current	4	3	3	4	4	3	6	4	3	1	1	1
Assets Current	47	53	50	32	33	38	44	36	40	37	41	12
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Assets	47	53	50	32	33	38	44	36	40	37	41	12
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	1	1	1	1	2	2	0	2	2	1	1
Accrued Liabilities Current	1	1	4	2	3	2	1	1	1	2	3	1
Deferred Revenue Current	1	1	1	1	1	1	1	1	1	1	1	-
Liabilities Current	4	4	6	4	5	4	4	2	4	4	5	2
Liabilities	4	4	7	5	5	5	5	4	5	5	6	2
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	119	118	105	84	82	81	80	70	69	63	62	37
Stockholders Equity Note Subscriptions Receivable	-	-	-	-	-	-	-	0	0	-0	-0	-
Retained Earnings Accumulated Deficit	-76	-69	-62	-56	-54	-48	-41	-38	-34	-31	-26	-27
Stockholders Equity	43	49	43	27	28	33	40	32	35	32	36	10
Liabilities And Stockholders Equity	47	53	50	32	33	38	44	36	40	37	41	12
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	23	23	21	17	17	17	17	15	15	15	14	10
Shares Outstanding	23	23	21	17	17	17	17	15	15	15	14	10

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	3.03%	36.60%	-4.90%	-	-	-	-	-	-	-	-	-
2025	2.08%	3.47%	5.73%	2.28%	-0.49%	3.10%	-1.15%	-7.22%	-23.65%	-7.33%	-8.67%	-1.78%
2024	-9.93%	-28.37%	-13.12%	13.83%	37.50%	33.33%	-10.19%	-18.46%	-18.73%	-19.84%	-6.20%	-8.84%
2023	-	-	-	-	-	-	35.95%	45.58%	20.83%	-10.43%	-18.47%	-28.60%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	13.40	15.02	8.50	8.73	7.43	8.84	11.59	15.31	10.43	8.64	8.15	6.54
Quick Ratio	12.29	14.30	7.97	7.67	6.61	8.18	10.02	13.39	9.56	8.33	7.94	6.03
Working Capital	43.55M	49.72M	44.07M	28.36M	28.93M	34.03M	40.48M	33.19M	36.06M	33.02M	36.14M	10.02M
Leverage & Debt
Debt to Equity	0.09	0.09	0.16	0.17	0.18	0.15	0.12	0.11	0.13	0.15	0.16	0.18
Debt Ratio	0.09	0.08	0.14	0.15	0.15	0.13	0.11	0.10	0.12	0.13	0.14	0.15
Efficiency & Turnover
Asset Turnover TTM	0.20	0.17	0.17	0.01	0.01	0.10	0.08	0.55	0.35	0.22	0.24	0.00
Per Share Metrics
Diluted EPS TTM	-0.92	-0.93	-1.27	-1.10	-1.22	-1.02	-0.98	-0.70	-0.68	-0.71	-0.79	-0.93
Free Cash Flow Per Share TTM	-0.53	-0.62	-0.64	-0.56	-0.82	-0.91	-0.68	-0.66	-0.46	-0.36	-1.10	-0.90
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-288.70%	-283.64%	-283.87%	-4,730.21%	-5,342.29%	-527.63%	-485.35%	-86.63%	-109.56%	-171.09%	-131.67%	-
Net Profit Margin TTM	-270.22%	-266.11%	-267.14%	-4,231.74%	-4,803.12%	-465.00%	-418.70%	-81.63%	-105.71%	-168.11%	-133.08%	-
Growth Metrics
Net Revenue Growth (1Y)	1,793.76%	115.44%	123.57%	-96.68%	-95.57%	-39.87%	-40.79%	-	-	-	-	-
Net Income Growth (1Y)	6.54%	23.29%	42.64%	72.29%	101.38%	66.31%	86.29%	15.62%	-	-	-	-
EPS Growth (1Y)	-24.04%	-8.96%	29.93%	56.73%	79.59%	43.81%	24.25%	-24.44%	-	-	-	-
Valuation Metrics
P/E TTM	-6.33	-4.22	-4.57	-5.17	-4.73	-6.31	-5.87	-9.18	-8.95	-13.92	-9.43	-4.13
P/B TTM	3.17	1.82	2.26	3.50	3.40	3.24	2.21	3.07	2.56	4.43	2.11	3.79
P/S TTM	17.11	11.24	12.21	218.96	227.11	29.36	24.57	7.49	9.46	23.40	12.55	-
Market Cap	137.22M	89.22M	97.04M	95.38M	96.17M	108.18M	87.32M	98.18M	90.39M	143.42M	75.31M	38.20M
Enterprise Value	94.04M	38.49M	50.21M	67.25M	66.41M	72.65M	48.98M	67.12M	53.81M	107.61M	42.87M	27.31M
Calculated Values
Free Cash Flow TTM	-12.34M	-14.12M	-10.74M	-9.31M	-13.64M	-15.26M	-10.29M	-10.12M	-6.87M	-5.18M	-11.19M	-8.95M
Net Debt	-43.18M	-50.72M	-46.82M	-28.13M	-29.76M	-35.53M	-38.34M	-31.06M	-36.58M	-35.81M	-32.44M	-10.89M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-11-14Purchase

Owner: Snyder, David S

Title: Chief Financial Officer

Shares: 1,800

Price/Share: $7.19

Value: $12,942.00

Shares Owned: 8,800

Relationship: Officer

Ownership: Direct

2024-11-13Purchase

Owner: Swaminathan, Arun

Title: Chief Executive Officer

Shares: 5,000

Price/Share: $7.36

Value: $36,800.00

Shares Owned: 10,000

Relationship: Director,Officer

Ownership: Direct

2024-11-11Purchase

Owner: Grossman, Fred

Title: Chief Medical Officer

Shares: 2,710

Price/Share: $7.37

Value: $19,972.70

Shares Owned: 2,710

Relationship: Officer

Ownership: Direct

2024-11-11Purchase

Owner: Swaminathan, Arun

Title: Chief Executive Officer

Shares: 5,000

Price/Share: $7.34

Value: $36,700.00

Shares Owned: 5,000

Relationship: Director,Officer

Ownership: Direct

2023-08-22Purchase

Owner: Lee, Ann

Title: -

Shares: 1,000

Price/Share: $3.62

Value: $3,620.00

Shares Owned: 17,479

Relationship: Director

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-11-14	Snyder, David S	Officer	Chief Financial Officer	Direct	Purchase	1,800	7.19	$12,942.00	8,800	4
2024-11-13	Swaminathan, Arun	Director,Officer	Chief Executive Officer	Direct	Purchase	5,000	7.36	$36,800.00	10,000	4
2024-11-11	Grossman, Fred	Officer	Chief Medical Officer	Direct	Purchase	2,710	7.37	$19,972.70	2,710	4
2024-11-11	Swaminathan, Arun	Director,Officer	Chief Executive Officer	Direct	Purchase	5,000	7.34	$36,700.00	5,000	4
2023-08-22	Lee, Ann	Director	-	Indirect	Purchase	1,000	3.62	$3,620.00	17,479	4
2023-01-03	Garren, Hideki	Director	-	Direct	Purchase	2,000	-	-	2,000	4
2023-01-03	Lee, Ann	Director	-	Direct	Purchase	10,000	-	-	10,000	4
2023-01-03	Goldstein, Dov A Md	Director	-	Direct	Purchase	10,000	-	-	10,000	4
2023-01-03	Berman, Howard	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	10,000	-	-	10,000	4
2023-01-03	Snyder, David S	Officer	Chief Financial Officer	Direct	Purchase	7,000	-	-	7,000	4
2023-01-03	Villalobos, Anabella	Director	-	Direct	Purchase	10,000	-	-	10,000	4
2023-01-03	Hepner, Adrian	Officer	Chief Medical Officer	Direct	Purchase	10,000	-	-	10,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

35.83%

Inst. Shares: 8,114,099

Shares Outstanding: 22,644,304

2025-12-31

47.21%

Inst. Shares: 7,898,715

Shares Outstanding: 16,730,274

2025-09-30

28.42%

Inst. Shares: 4,754,854

Shares Outstanding: 16,732,766

2025-06-30

26.83%

Inst. Shares: 4,486,560

Shares Outstanding: 16,724,998

2025-03-31

27.89%

Inst. Shares: 4,662,591

Shares Outstanding: 16,720,511

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	8,114,099	22,644,304	35.83%
2025-12-31	7,898,715	16,730,274	47.21%
2025-09-30	4,754,854	16,732,766	28.42%
2025-06-30	4,486,560	16,724,998	26.83%
2025-03-31	4,662,591	16,720,511	27.89%
2024-12-31	4,443,112	15,238,919	29.16%
2024-09-30	3,315,161	15,221,308	21.78%
2024-06-30	3,268,292	14,915,217	21.91%
2024-03-31	3,338,860	14,457,839	23.09%
2023-12-31	2,821,193	10,163,850	27.76%
2023-09-30	1,415,507	9,947,915	14.23%
2023-06-30	1,291,006	9,947,915	12.98%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Coya Therapeutics, Inc. (COYA) — SEC Financial Statements & Analysis

Coya Therapeutics, Inc. (COYA) is a pharmaceutical preparations company, incorporated in DE. Coya Therapeutics, Inc. trades on Nasdaq as: COYA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Coya Therapeutics, Inc. reported a 1793.76% year-over-year revenue growth, a Debt-to-Equity ratio of 0.09x, a Price-to-Sales (P/S) ratio of 17.11x (TTM), a Price-to-Book (P/B) ratio of 3.17x (TTM), at a market cap of $137.22M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 1793.76%
Debt To Equity: 0.09x
P/S TTM: 17.11x
P/B TTM: 3.17x
Market Cap: $137.22M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Coya Therapeutics, Inc. in?

Coya Therapeutics, Inc. (COYA) operates in the Pharmaceutical Preparations industry.

What is COYA's market cap?

Coya Therapeutics, Inc. (COYA) has a market capitalization of $137.22M as of 2026-06-30.

What exchange does COYA trade on?

Coya Therapeutics, Inc. (COYA) trades on the Nasdaq.

Where is Coya Therapeutics, Inc. incorporated?

Coya Therapeutics, Inc. is incorporated in DE.